ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO711

Anti-Glomerular Basement Membrane Disease Overlap with Pauci-Immune Glomerulonephritis: Temporal Concurrence at a Single Center

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: From Inflammation to Fibrosis

Authors

  • Fechter, Buckley, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Batool, Aisha, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Gallan, Alexander James, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Chaudhry, Shahzad, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
  • Mariyam Joy, Christina, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Introduction

Anti-GBM and pauci-immune vasculitis are small vessel vasculitis and cause RPGN with diffuse alveolar hemorrhage (DAH). Overlap between these entities is rare. Upto 38% of the individuals with anti-GBM disease demonstrate double-positivity and approximately 10% of patients with ANCA vasculitis have positive titers of anti-GBM antibodies. We present two double-positive cases diagnosed within 6 weeks at our institution.

Case Description

Case 1:A 74-years-old white male with h.o SARS-COV19 two months ago presented with cough and metallic taste, BUN 60 with S/Cr 5.05 mg/dl, p-ANCA 1:640 and anti-GBM+. Kidney biopsy showing Diffuse crescentic GN with cellular crescents involve 50% of the glomeruli,IF linear IgG staining. Patient was started on PLEX, IV Methylprednisolone and Cyclophosphamide. Patient remains HD dependent.
Case 2:A 71-years-old white male with recently diagnosed lung biopsy proven GPA 4 months ago. Patient was admitted with SARS-COV-19 infection, serum creatinine 6.42mg/dl (baseline 0.9mg/dl few months ago). Kidney biopsy showing Crescentic glomerulonephritis with overlapping anti-glomerular basement membrane disease and pauci-immune glomerulonephritis. Patient was started on iv methylprednisolone, PLEX and cyclophosphamide. Patient needed hemodialysis for 2.5 months and has come off with most recent s/cr 3.54 mg/dl.

Discussion

In anti-GBM disease DAH can be the predominant presenting feature and will prompt early diagnosis necessitating early intervention. Hallmark for diagnosis is linear IgG staining of GBM on immunofluorescence. ANCA-associated vasculitis, in contrast, is pauci-immune with few or no immune deposits on IF. Given rarity of the overlap disease and paucity of literature standard treatment strategy is not established. Approach remains similar to treatment of anti GBM disease with PLEX and induction immunosuppression with cyclophosphamide. However longer and closer follow-up is required for double-positive disease due to more frequent relapses.